August 3, 2026 August 3, 2026Categories Announcements News StoriesThe July 2026 News from ECOG-ACRIN blog is now available
July 9, 2026 July 9, 2026Categories News StoriesPodcast: ASCO Post includes updated STAMP (EA6174) Merkel cell carcinoma data in its ASCO26 highlights, applauding cooperative groups for their ability to study rare cancers
June 29, 2026 June 29, 2026Categories Announcements News StoriesThe June 2026 News from ECOG-ACRIN blog is now available
June 4, 2026 June 4, 2026Categories News StoriesA new exploratory analysis from STAMP (EA6174) on aggressive Merkel cell cancer draws attention at ASCO 2026
June 2, 2026 June 2, 2026Categories News StoriesEA5142, an ALCHEMIST trial, adds to the knowledge base about optimal timing of adjuvant immunotherapy in non-small cell lung cancer
June 2, 2026 June 2, 2026Categories News StoriesWATCH: Dr. Jamie Chaft discusses the results of ALCHEMIST EA5142, a randomized phase 3 study of nivolumab after surgery and adjuvant chemotherapy in non-small cell lung cancer
June 1, 2026 June 1, 2026Categories News StoriesJAMA publishes ALCHEMIST EA5142 results: Nivolumab does not further reduce the risk of recurrence in patients with resected non-small cell lung cancer
May 28, 2026 May 28, 2026Categories Announcements News StoriesThe May 2026 News from ECOG-ACRIN blog is now available
May 15, 2026 May 15, 2026Categories Announcements News StoriesThe Spring 2026 advocacy blog Considering Clinical Trials is now available
